SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 7th, 2020 • Idera Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is made and entered into as of April 7, 2020 (the “Effective Date”) by and among Idera Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Pillar Partners Foundation, L.P., a Cayman Islands limited partnership (the “Purchaser”). Certain terms used and not otherwise defined in the text of this Agreement are defined in Section 11 hereof.
VOTING AGREEMENTVoting Agreement • April 7th, 2020 • Idera Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Delaware
THIS VOTING AGREEMENT (this “Agreement”) is entered into as of April 7, 2020, by and between Pillar Partners Foundation, L.P., a Cayman Islands limited partnership (the “Investor”) and Idera Pharmaceuticals, Inc., a Delaware corporation (the “Company”). Capitalized terms used herein but not otherwise defined shall have the meaning given to them in the Purchase Agreement (as defined below).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 7th, 2020 • Idera Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
This Registration Rights Agreement (this “Agreement”) is made as of April 7, 2020, by and between Idera Pharmaceuticals, Inc., a Delaware corporation (the “Company”) and Pillar Partners Foundation, L.P., a Cayman Islands limited partnership (the “Investor”). Unless otherwise defined herein, capitalized terms used in this Agreement have the respective meanings ascribed to them in Section 1.
